RT @weldeiry: I wanted to share regarding targeting hypoxic tumors: https://t.co/qEfzBf6qzr https://t.co/dv6LaFjSiV and clinical trial in b…
RT @weldeiry: I wanted to share regarding targeting hypoxic tumors: https://t.co/qEfzBf6qzr https://t.co/dv6LaFjSiV and clinical trial in b…
I wanted to share regarding targeting hypoxic tumors: https://t.co/qEfzBf6qzr https://t.co/dv6LaFjSiV and clinical trial in breast cancer that is now IRB-approved is about to start here @BrownUCancer @BrownOncology @LifespanHlthSys @carenewengland https:/
RT @weldeiry: Very pleased to share our latest discovery @BrownUCancer #eldeirylab and congratulations to Dr. Shuai Zhao "Identification of…
And the underlying mechanisms are also interesting Identification of Smurf2 as a HIF-1α degrading E3 ubiquitin ligase https://t.co/dv6LaFjSiV
RT @weldeiry: For our interested colleagues, our followup paper identifying Smurf2 as a VHL-independent HIF-degrading E3 ligase in CDK4/6 i…
RT @weldeiry: For our interested colleagues, our followup paper identifying Smurf2 as a VHL-independent HIF-degrading E3 ligase in CDK4/6 i…
For our interested colleagues, our followup paper identifying Smurf2 as a VHL-independent HIF-degrading E3 ligase in CDK4/6 inhibitor treated cells, see https://t.co/3bc9E1GmcD and https://t.co/dv6LaFjSiV #eldeirylab @BrownUCancer @BrownPathology @BrownUPa
For our interested colleagues, our followup paper identifying Smurf2 as a VHL-independent HIF-degrading E3 ligase in CDK4/6 inhibitor treated cells, see https://t.co/3bc9E1GmcD and https://t.co/dv6LaFjSiV #eldeirylab @BrownUCancer @BrownPathology @BrownUPa
New article: Identification of Smurf2 as a HIF-1α degrading E3 ubiquitin ligase https://t.co/IgFkPPmoWc #colorectalcancer #oncology https://t.co/1o4Rm9Ya6p
RT @Oncotarget: Researchers from @BrownMedicine & Lifespan Cancer Institute authored Oncotarget's latest cover #paper: "Identification of S…
RT @Oncotarget: Researchers from @BrownMedicine & Lifespan Cancer Institute authored Oncotarget's latest cover #paper: "Identification of S…
RT @Oncotarget: Researchers from @BrownMedicine & Lifespan Cancer Institute authored Oncotarget's latest cover #paper: "Identification of S…
RT @weldeiry: Very pleased to share our latest discovery @BrownUCancer #eldeirylab and congratulations to Dr. Shuai Zhao "Identification of…
Researchers from @BrownMedicine & Lifespan Cancer Institute authored Oncotarget's latest cover #paper: "Identification of Smurf2 as a HIF-1α degrading E3 ubiquitin ligase" Read the full priority #research paper: https://t.co/oPGOIqUsNJ #eldeirylab @Br
The #PaperoftheDay is the cover of Oncotarget's latest issue: "Identification of Smurf2 as a HIF-1α degrading E3 ubiquitin ligase" https://t.co/oPGOIqUsNJ #hypoxia #cancer #cancertherapy #openaccess #science #medicine #genes #medEd #OA
RT @weldeiry: Very pleased to share our latest discovery @BrownUCancer #eldeirylab and congratulations to Dr. Shuai Zhao "Identification of…
RT @weldeiry: Very pleased to share our latest discovery @BrownUCancer #eldeirylab and congratulations to Dr. Shuai Zhao "Identification of…
RT @Oncotarget: The cover of Oncotarget's latest issue features Figure 8, "Proposed model of Smurf2-mediated HIF-1α regulation," by Zhao, e…
The cover of Oncotarget's latest issue features Figure 8, "Proposed model of Smurf2-mediated HIF-1α regulation," by Zhao, et al. https://t.co/a84uW7yVcI #hypoxia #cancer #cancertherapy #medEd #OA
RT @weldeiry: Very pleased to share our latest discovery @BrownUCancer #eldeirylab and congratulations to Dr. Shuai Zhao "Identification of…
RT @weldeiry: Very pleased to share our latest discovery @BrownUCancer #eldeirylab and congratulations to Dr. Shuai Zhao "Identification of…
Very pleased to share our latest discovery @BrownUCancer #eldeirylab and congratulations to Dr. Shuai Zhao "Identification of Smurf2 as a HIF-1α degrading E3 ubiquitin ligase" https://t.co/DTrlWnOeot @Oncotarget @BrownMedicine @BrownUResearch @BrownUnivers